Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Sage, Despite Industry-Wide Pullback, Scores $90M in Upsized IPO 07/17/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
New Jounce CEO Aims to Place the Right Immuno-Oncology Bets 07/11/14 Boston
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
BIO 2014: An Industry Surrounded by Insurmountable Opportunity 06/19/14 San Diego
Zafgen Hauls In $96M in Upsized IPO 06/18/14 Boston
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
One More Thought From Boston 2034: Tech + Biotech + Cleantech = ? 06/17/14 Boston
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study 06/14/14 Boston
Lou Tartaglia Leaves Third Rock to Run High-Drama RNAi Startup 06/09/14 San Diego
Boston Consumer Tech and 4 Views of the Future: A 2034 Preview 06/04/14 Boston
As Expected, Nurix Taps Into $25M for New Drug Discovery 05/22/14 San Francisco
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
Rhythm Eyes Pivotal Study as GI Drug for Diabetics Hits Phase 2 Mark 05/06/14 Boston
Lightstone Closes $172M Fund for Early-Stage Biotechs 05/01/14 Boston
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Two San Francisco Startups Sharing In Third Rock’s Rich Third Fund 04/24/14 San Francisco
Kala Pharma Grabs $22.5M More For Eye Drugs 04/23/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push 04/20/14 Boston
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia 04/15/14 Boston
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Page 1 of 12 next page »